CHEMPARTNER PHARMATECH CO., LTD. Chempartner Pharmatech Co., Ltd. Share Price
Equities
300149
CNE100000Y27
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.27 CNY | +1.74% |
|
+19.23% | -31.11% |
| Sales 2022 | 1.33B 183M 14.62B | Sales 2023 | 1.14B 157M 12.55B | Capitalization | 3.81B 526M 42B |
|---|---|---|---|---|---|
| Net income 2022 | 379M 52.34M 4.18B | Net income 2023 | -908M -125M -10.01B | EV / Sales 2022 | 4.06 x |
| Net Debt 2022 | 205M 28.25M 2.25B | Net Debt 2023 | 286M 39.48M 3.15B | EV / Sales 2023 | 3.6 x |
| P/E ratio 2022 |
13.7
x | P/E ratio 2023 |
-4.2
x | Employees | 2,072 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 23.07% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.74% | ||
| 1 week | +19.23% | ||
| Current month | -4.53% | ||
| 1 month | -4.53% | ||
| 3 months | -13.75% | ||
| 6 months | -37.04% | ||
| Current year | -31.11% |
1 week
4.59
5.30
1 month
4.135.90
Current year
3.687.65
1 year
3.689.74
3 years
3.6820.82
5 years
3.6824.89
10 years
3.6828.55
| Managers | Title | Age | Since |
|---|---|---|---|
Ji Guo Zhang
CEO | Chief Executive Officer | 51 | 07/02/23 |
Yin Qun Cha
DFI | Director of Finance/CFO | 45 | 07/10/23 |
Hong Hui Li
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xin Hui
BRD | Director/Board Member | 53 | 31/07/18 |
Chi Shing Kwok
BRD | Director/Board Member | 62 | 11/10/20 |
Xian Zhong Wang
BRD | Director/Board Member | 54 | 22/08/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 5.27 | +1.74% | 9,117,744 |
| 29/04/24 | 5.18 | +4.65% | 9,062,478 |
| 26/04/24 | 4.95 | +2.70% | 7,614,463 |
| 25/04/24 | 4.82 | +1.90% | 7,133,814 |
| 24/04/24 | 4.73 | +1.94% | 6,408,600 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
ChemPartner PharmaTech Co Ltd, formerly Quantum Hi-tech China Biological Co Ltd, is a China-based company principally engaged in the research, development, production, and sales of fructooligosaccharides and other prebiotics. The Company's main products include fructooligosaccharides and galactooligosaccharides. The Company owns brands names of FOS and GOS. The Company's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The Company distributes its products mainly in domestic market, with South China as its main market.
Calendar
31/05/2024
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.11% | 363M | |
| +0.67% | 42.19B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +6.55% | 24.63B | |
| -21.66% | 18.2B | |
| +29.96% | 12.01B | |
| -1.57% | 11.76B | |
| +16.03% | 10.4B | |
| -4.80% | 9.94B |
- Stock Market
- Equities
- 300149 Stock
